NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Thursday, July 26th. Stockholders of record on Friday, September 14th will be given a dividend of $0.335 per share on Monday, October 1st. This represents a $1.34 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date is Thursday, September 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Tuesday, August, 7th. The specialty chemicals company reported $1.36 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.08. The specialty chemicals company earned $853.87 million during the quarter, compared to analyst estimates of $799.49 million. Albemarle had a return on equity of 14.51% and a net margin of 10.17%. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY18 earnings guidance on Tuesday, August, 7th. The company provided EPS guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus estimate of $5.26. The company issued revenue guidance of $3.3-3.5 vln, compared to the consensus revenue estimate of $3.32 billion.

21 Wall Street analysts have issued 1 year target prices for Albemarle's stock. Their predictions range from $106.00 to $157.00. On average, they expect Albemarle's share price to reach $133.5283 in the next twelve months. This suggests a possible upside of 26.6% from the stock's current price. View Analyst Price Targets for Albemarle.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 1 hold rating and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), Cereplast (CERPQ) and ForceField Energy (FNRG).

Media stories about ALB stock have been trending somewhat positive on Thursday, Accern reports. The research group scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a news impact score of 0.18 on Accern's scale. They also gave news articles about the specialty chemicals company an impact score of 46.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Albemarle.

Albemarle's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.50%), Jennison Associates LLC (6.62%), Bank of New York Mellon Corp (4.88%), Baillie Gifford & Co. (2.36%), Iridian Asset Management LLC CT (1.83%) and Global X Management Co LLC (1.43%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Janus Henderson Group PLC, Baird Financial Group Inc., FMR LLC, Dividend Assets Capital LLC, Bank of New York Mellon Corp, Artisan Partners Limited Partnership and BlackRock Inc.. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Jennison Associates LLC, Advisors Asset Management Inc., Rovida Advisors Inc., Sei Investments Co., Joho Capital LLC, Federated Investors Inc. PA and Handelsbanken Fonder AB. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $105.49.

Albemarle has a market capitalization of $11.18 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.